Showing results (21-30 of 113) with videos related to
Sort By:
Pageof 12
Arthritis Research|July 12, 2002
The paradigm of IL-6: from basic science to medicineTetsuji Naka, Norihiro Nishimoto, Tadamitsu KishimotoModern Rheumatology|March 12, 2010
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensionsNorihiro Nishimoto, Kyoko Ito, Nobuhiro TakagiExpert Opinion on Biological Therapy|June 7, 2005
The therapy of autoimmune diseases by anti-interleukin-6 receptor antibodyMasahiko Mihara, Norihiro Nishimoto, Yoshiyuki OhsugiOpen Access Rheumatology : Research and Reviews|July 4, 2012
Tocilizumab in the treatment of systemic juvenile idiopathic arthritisMiho Murakami, Minako Tomiita, Norihiro NishimotoCurrent Pharmaceutical Design|May 14, 2008
The blockade of IL-6 signaling in rational drug designYasuo Adachi, Naoko Yoshio-Hoshino, Norihiro NishimotoCurrent Gene Therapy|August 12, 2008
Gene therapy for multiple myelomaYasuo Adachi, Naoko Yoshio-Hoshino, Norihiro NishimotoJournal of Biomedicine & Biotechnology|April 24, 2010
Cytokine networks in systemic lupus erythematosusHooi-Ming Lee, Hidehiko Sugino, Norihiro NishimotoImmunology Letters|November 5, 2002
Influences of anti-mouse interleukin-6 receptor antibody on immune responses in miceMasahiko Mihara, Norihiro Nishimoto, Kazuyuki Yoshizaki, et al.BMJ Case Reports|August 11, 2011
Progression of viraemia during treatment with infliximab in a patient with rheumatoid arthritis and chronic hepatitis C infectionHiroshi Uda, Makihiko Kuhara, Norihiro Nishimoto, et al.Anticancer Research|July 24, 2010
VEGF targeting in mesotheliomas using an interleukin-6 signal inhibitor based on adenovirus gene deliveryYasuo Adachi, Naoko Yoshio-Hoshino, Chieko Aoki, et al.Pageof 12